Stay updated on CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Sign up to get notified when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.

Latest updates to the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the Record History, reflecting metadata updates rather than substantive study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter updated: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2; no study data or record history content changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check47 days agoChange DetectedNew revision entry v3.3.2 was added and v3.3.1 was removed in the Record History. This is a versioning update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check54 days agoChange DetectedThe record history shows an added revision v3.3.1 and a removed revision v3.2.0.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page removes the general funding/operating status notice paragraph. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check75 days agoChange DetectedThere are no substantive changes between versions; the history shows version dates and 'None' for Changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.